GT Biopharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US36254L3087
USD
0.61
-0.02 (-3.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGT Biopharma, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-3.24%
0.19%
1W
-22.87%
0.31%
1M
-0.15%
1.09%
YTD
-80.02%
16.81%
1Y
-75.44%
13.09%
3Y
-98.56%
71.81%
5Y
-99.4%
85.73%
10Y
-99.4%
228.46%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-35.51%
0%
-35.51%
6 Months
-77.44%
0%
-77.44%
1 Year
-75.44%
0%
-75.44%
2 Years
-91.61%
0%
-91.61%
3 Years
-98.56%
0%
-98.56%
4 Years
-99.36%
0%
-99.36%
5 Years
-99.4%
0%
-99.4%

GT Biopharma, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary